Patents by Inventor Charles Q. Huang

Charles Q. Huang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRF receptor antagonists and methods relating thereto
    Patent number: 6514982
    Abstract: CRF receptor antagonists are disclosed which have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in a warm-blooded animals, such as stroke. The CRF receptor antagonists of this invention have the following structure: including stereoisomers and pharmaceutically acceptable salts thereof, wherein n, m, A, B, C, R, R1, R2 and Ar are as defined herein.
    Type: Grant
    Filed: November 12, 1999
    Date of Patent: February 4, 2003
    Assignee: Neurocrine Biosciences, Inc.
    Inventors: Mustapha Haddach, Brian P. Dyck, Charles Q. Huang, Jodie Nelson, Zhiqiang Guo, James R. McCarthy
  • CRF receptor antagonists and methods relating thereto
    Publication number: 20020151557
    Abstract: CRF receptor antagonists are disclosed which have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in a warm-blooded animals, such as stroke.
    Type: Application
    Filed: November 2, 2001
    Publication date: October 17, 2002
    Applicant: Neurocrine Biosciences, Inc
    Inventors: Mustapha Haddach, Marion C. Lanier, Charles Q. Huang, James R. McCarthy
  • Dynamic subject information generation in message services of distributed object systems
    Publication number: 20020103866
    Abstract: A system, method and medium of sending messages in a distributed data processing network is described, and contemplates receiving a message that includes subject information that is generated based on one or more pre-selected portions as the message is generated. A message delivery system in a client-server environment is also described. The message delivery system includes a server configured to receive a message that includes subject information that is generated based on one or more pre-selected portions as the message is created and configured to forward the message based on the subject information.
    Type: Application
    Filed: November 30, 2000
    Publication date: August 1, 2002
    Inventors: Yueh-shian T. Chi, Parris C.M. Hawkins, Charles Q. Huang
  • Compounds and methods for increasing endogenous levels of corticotropin-releasing factor
    Patent number: 6133276
    Abstract: Ligand inhibitors for increasing levels of free corticotropin-releasing factor (CRF) in the brain are disclosed. Such ligand inhibitors cause release of CRF from the CRF/CRF-bind protein complex. Administration of the ligand inhibitors provide improvement in learning and memory, result in decreased food intake and/or provide treatment for diseases associated with low levels of CRF in the brain, notably Alzheimer's disease.
    Type: Grant
    Filed: December 29, 1998
    Date of Patent: October 17, 2000
    Assignee: Neurocrine Biosciences, Inc.
    Inventors: Jeffrey P. Whitten, James R. McCarthy, Zhengyu Liu, Charles Q. Huang, Philip E. Erickson, Dominic P. Behan
  • Compounds and methods for increasing endogenous levels of corticotropin-releasing factor
    Patent number: 5959109
    Abstract: Ligand inhibitors for increasing levels of free corticotropin-releasing factor (CRF) in the brain. Such ligand inhibitors cause release of CRF from the CRF/CRF-binding protein complex. Administration of the ligand inhibitors provide improvement in learning and memory, result in decreased food intake and/or provide treatment for diseases associated with low levels of CRF in the brain, notably Alzheimer's disease.
    Type: Grant
    Filed: May 15, 1996
    Date of Patent: September 28, 1999
    Assignee: Neurocrine Biosciences, Inc.
    Inventors: Jeffrey P. Whitten, James R. McCarthy, Zhengyu Liu, Charles Q. Huang, Philip E. Erickson, Dominic P. Behan